Navigation Links
Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)
Date:9/3/2008

NEW YORK, Sept. 3 /PRNewswire/ -- Concentric Pharma Advertising, one of the fastest growing marketing agencies in the healthcare field, has been named agency of record by Discovery Labs for SURFAXIN(R) (lucinactant), an investigational drug being reviewed by the Food and Drug Administration for the treatment of respiratory distress syndrome (RDS) in newborns.

"We selected Concentric for this assignment because the company's strategic insight and creative vision best captured the essence of the SURFAXIN brand," said John Wilson, vice president of sales and marketing at Discovery, adding that the agency's in-depth knowledge of neonatology and acute RDS in premature infants also played a significant part in the decision.

The full-service U.S. assignment will include a wide range of activities, including corporate and product branding, positioning, and the creation of support materials geared to neonatologists, neonatal intensive care unit (NICU) nurses, respiratory therapists, hospital pharmacists, and, potentially, parents of newborns. The agency's account team will be led by Ed Mutch, account supervisor. Blake Benner, director of marketing at Discovery Labs, will manage the account on the client side.

Discovery Labs, headquartered in Warrington, Pa., is a biotechnology company developing novel surfactant replacement therapies (SRTs) with potential for application across the continuum of respiratory diseases, initially focusing on RDS in premature infants.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing firm established in 2002, is one of the fastest growing agencies in the healthcare field, enjoying double-digit revenue growth for the fourth year in a row. In the past year alone, the agency won 10 new assignments, launched a new division, expanded its senior management team, and won several awards in prestigious U.S. and global ad competitions.

Concentric offers a wid
'/>"/>

SOURCE Concentric Pharma Advertising
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
2. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
3. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
4. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
9. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
10. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
11. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Drug safety specialty firm Bio...ning and Informatics earned the Certified Professi...dential from the American Society for Training and...elle Flewell has more than fifteen years of medica...ce and is responsible for the development of the c...
(Date:11/5/2009)... Brooke Sanders brings a new lo... CA (PRWEB) November 5, 2009 -- Professional Repro...prographics company is pleased to present Brooke S... their graphics/PR specialist. The addition of Bro...tent growth within Professional Reprographics., , ...
(Date:11/4/2009)... The Human Anthrax Vaccine Prog... completed the feature film "A Call to Arms:2...mentary "Fatal Immunity: The Human Anthrax Va...lear and present danger of top secret government s...es with no accountability to its victims. It is a...
(Date:11/4/2009)...PETERSBURG, Va., Nov. 4 ...ed today that the company plans to introduce the C...bsidiary, Rock Creek Pharmaceuticals, for worldwid...iv Health, Inc . (Nasdaq: VTIV). inVentiv Health...tions for every stage of the product lifecycle, in...
Breaking Biology Technology:BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4
... Inc. (Nasdaq and SWX: BMRN) announced today that ...idiary of Daiichi Sankyo),exclusive rights to data...TM) (sapropterin dihydrochloride) new drug applica...t its current filing to the Japanese,Ministry of H...product for,the treatment of phenylketonuria (PKU)...
...otech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: A...agreement with Johnson & Johnson,s subsidiary, Con...patent litigation with respect to Conor,s,CoStar(R...lace, Angiotech expects that the resources,require...should decrease,",said Dr. William Hunter, Preside...
... (Nasdaq: KERX ) today announced that I. Craig He... an overview of the Company,s cancer,pipeline at t... Conference,in San Francisco. Dr. Henderson,s pres...9th at 8:30 am PT. Dr. Henderson,s presentation w...e Investor Information page of the Company,s Websi...
Other Biology Technology:Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 2Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 3Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 4Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 2Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 4Keryx Biopharmaceuticals to Present at Bank of America Investment Conference 2
(Date:11/8/2009)...09) The loss of a gene through deletion of geneti...nificant abnormalities in learning and behavior, s...ege of Medicine ( www.bcm.edu ) in a report that a...s . , "This research goes about 95 percent of th...p of individuals to this gene," said Dr. Arthur L....
(Date:11/6/2009)...ally live in harmony with their arboreal hosts. Bu...space in their trees of choice, the ants can get d... published in the November issue of the American ...re into live trees, and it reopens a centuries-old...s. , Ants and certain species of plants and tree...
(Date:11/5/2009)...ers at Yale University have developed synthetic mo...ponse to HIV and HIV-infected cells, as well as to...online in the Journal of the American Chemical So... for these diseases. , The molecules called "a... and "antibody-recruiting molecule targeting prost...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 1Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 2Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 3Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 4Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 5Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 6Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 1Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 2The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 1The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 2
...elease is available in German . , Leipzig. Fallo... are evidently capable of having a much greater ef...umed. This is the conclusion drawn by researchers ...hed fields in southern Ukraine and led to extremel...tral Europe. On 24 March 2007 the dust cloud sprea...
...of young schoolchildren from a remote Siberian vil...play at the American Association for the Advanceme...W, Washington, D.C. , The children, who are 9-14...uestions from the audience via a videoteleconferen...orium. The works, mainly watercolors and some char...
...eak of the insidious screw worm fly in Yemen, is t... livestock is a traditional way of life. In recent...n Vienna, Austria, to turn to the international co...ly pest. , The menacing fly lays its eggs in a cu...ots then feast off the living flesh, and can kill ...
Other Biology News:Arable land can have a negative impact on air quality 2Arable land can have a negative impact on air quality 3Arable land can have a negative impact on air quality 4Arable land can have a negative impact on air quality 5May 14 AAAS Lecture and videoteleconference on artworks by Siberian schoolchildren 2Screw worm outbreak in Yemen 2Screw worm outbreak in Yemen 3
Silencer Pre-designed siRNA, standard purity from Ambion
Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Silencer Pre-designed siRNA, HPLC purified from Ambion
PCR-CleanUp Mix from Yorkshire Bioscience Ltd
Biology Products: